PNPLA3 and metabolic dysfunction-associated steatohepatitis: Zhou et al. [43] proposed a large study (318 subjects) comparing the MS-based profiling of plasma, the routinely available clinical parameters, and the patatin-like phospholipase domain-containing protein 3 (PNPLA3) genotype as potential tools for diagnosis of NASH.